← Back
$AVIR All transactions

Atea Pharmaceuticals, Inc.

A

$ Value

$0

Shares

164,800

Price

$0

Filed

Jun 24

Insider

Name

Berman Howard

Title

CIK

0001952986

Roles

Director

Transaction Details

Transaction Date

2025-06-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

164,800

Footnotes

The option vests and becomes exercisable in thirty-six (36) equal monthly installments following June 20, 2025 such that the option is fully vested on June 20, 2028.

Filing Info

Accession No.

0000950170-25-089603

Form Type

4

Issuer CIK

0001593899

Berman Howard's History

Date Ticker Type Value
2026-01-22 COYA A $0
2025-06-20 AVIR A $0

Other Insiders at AVIR (90d)

Insider Bought Sold Last
Sommadossi Jean-Pierre
President, CEO, and Chairman
2026-02-03
Corcoran Andrea
See Remarks
2026-03-11
Foster Wayne
EVP, Chief Accounting Officer
2026-01-31
Horga Maria Arantxa
Chief Medical Officer
2026-01-31
Vavricka John
Chief Commercial Officer
2026-01-31
Hammond Janet MJ
Chief Development Officer
2026-01-31